Home > Insider Trading > Filing (0001209191-22-039690)

Filing Details

Accession Number:: 0001209191-22-039690
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2022-06-28 19:46:04
Reporting Period:: 2022-04-14

Accepted Time:: 2022-06-28 19:46:04
Original Submission Date:: 2022-04-18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1642380	Oncocyte Corp	OCX	()	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1590144	Pura Vida Investments, Llc	512 W 22Nd Street 7Th Floor New York NY 10011		No	No	Yes	No
1789193	Efrem Kamen	C/O Pura Vida Investments, Llc 512 W 22Nd Street, 7Th Floor New York NY 10011		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-04-14	30,790	$1.23	7,381,237	No	4	P	Indirect	By Pura Vida Master Fund, Ltd.
Common Stock	Acquisiton	2022-04-14	92,370	$1.26	7,473,607	No	4	P	Indirect	By Pura Vida Master Fund, Ltd.
Common Stock	Acquisiton	2022-04-14	19,210	$1.23	8,475,033	No	4	P	Indirect	By the Managed Accounts.
Common Stock	Acquisiton	2022-04-14	57,630	$1.26	8,532,663	No	4	P	Indirect	By the Managed Accounts.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Pura Vida Master Fund, Ltd.
No	4	P	Indirect	By Pura Vida Master Fund, Ltd.
No	4	P	Indirect	By the Managed Accounts.
No	4	P	Indirect	By the Managed Accounts.

Footnotes

Aggregate number of shares purchased on the same date at difference prices.
Represents the weighted-average purchase price. The shares were purchased in multiple transactions at prices ranging from $1.19 to $1.27, inclusive, per share. Full information regarding the number of shares purchased at each price shall be provided to the Securities and Exchange Commission staff (the "Staff"), Issuer or any security holder, upon request.
Shares reported herein are owned by Pura Vida Master Fund, Ltd. (the "Pura Vida Master Fund") and certain separately managed accounts (the "Managed Accounts," and together with the Pura Vida Master Fund, collectively the "Client Accounts"). Pura Vida Investments, LLC ("PVI") serves as the investment manager or sub-adviser to the Client Accounts. Efrem Kamen serves as the Managing Member of PVI.
By virtue of these relationships, the Reporting Persons may be deemed to have shared voting and dispositive power with respect to the securities owned directly by the Client Accounts. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein, if any.
Represents the weighted-average purchase price. The shares were purchased in multiple transactions at prices ranging from $1.235 to $1.305, inclusive, per share. Full information regarding the number of shares purchased at each price shall be provided to the Staff, Issuer or any security holder, upon request.